Merit Medical Systems, Inc. (MMSI)
USD 88.48
(-4.36%)
USD 88.48
(-4.36%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.32 Billion USD | 39.74% |
| 2022 | 1.66 Billion USD | 0.95% |
| 2021 | 1.64 Billion USD | -0.97% |
| 2020 | 1.66 Billion USD | -5.29% |
| 2019 | 1.75 Billion USD | 8.48% |
| 2018 | 1.62 Billion USD | 45.71% |
| 2017 | 1.11 Billion USD | 17.93% |
| 2016 | 942.8 Million USD | 21.07% |
| 2015 | 778.72 Million USD | 4.22% |
| 2014 | 747.16 Million USD | 2.59% |
| 2013 | 728.28 Million USD | 3.26% |
| 2012 | 705.3 Million USD | 57.78% |
| 2011 | 447.01 Million USD | 20.84% |
| 2010 | 369.93 Million USD | 36.25% |
| 2009 | 271.51 Million USD | 17.14% |
| 2008 | 231.77 Million USD | 15.65% |
| 2007 | 200.42 Million USD | 9.72% |
| 2006 | 182.66 Million USD | 12.59% |
| 2005 | 162.24 Million USD | 15.99% |
| 2004 | 139.87 Million USD | 30.36% |
| 2003 | 107.3 Million USD | 37.03% |
| 2002 | 78.3 Million USD | 17.47% |
| 2001 | 66.65 Million USD | -6.7% |
| 2000 | 71.44 Million USD | -1.32% |
| 1999 | 72.4 Million USD | 42.8% |
| 1998 | 50.7 Million USD | 11.92% |
| 1997 | 45.3 Million USD | 8.63% |
| 1996 | 41.7 Million USD | 20.87% |
| 1995 | 34.5 Million USD | 27.78% |
| 1994 | 27 Million USD | 31.71% |
| 1993 | 20.5 Million USD | 25.0% |
| 1992 | 16.4 Million USD | 74.47% |
| 1991 | 9.4 Million USD | 154.05% |
| 1990 | 3.7 Million USD | 131.25% |
| 1989 | 1.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.37 Billion USD | 0.26% |
| 2024 Q1 | 2.32 Billion USD | 0.05% |
| 2024 Q2 | 2.37 Billion USD | 1.96% |
| 2023 FY | 2.32 Billion USD | 39.74% |
| 2023 Q4 | 2.32 Billion USD | 28.57% |
| 2023 Q1 | 1.68 Billion USD | 1.21% |
| 2023 Q2 | 1.83 Billion USD | 9.11% |
| 2023 Q3 | 1.8 Billion USD | -1.58% |
| 2022 FY | 1.66 Billion USD | 0.95% |
| 2022 Q2 | 1.63 Billion USD | 0.11% |
| 2022 Q4 | 1.66 Billion USD | 1.91% |
| 2022 Q3 | 1.63 Billion USD | 0.07% |
| 2022 Q1 | 1.62 Billion USD | -1.13% |
| 2021 Q2 | 1.64 Billion USD | -0.56% |
| 2021 FY | 1.64 Billion USD | -0.97% |
| 2021 Q4 | 1.64 Billion USD | 0.31% |
| 2021 Q3 | 1.64 Billion USD | 0.05% |
| 2021 Q1 | 1.65 Billion USD | -0.76% |
| 2020 FY | 1.66 Billion USD | -5.29% |
| 2020 Q1 | 1.74 Billion USD | -0.46% |
| 2020 Q4 | 1.66 Billion USD | -0.37% |
| 2020 Q3 | 1.67 Billion USD | -2.64% |
| 2020 Q2 | 1.71 Billion USD | -1.91% |
| 2019 Q4 | 1.75 Billion USD | -0.25% |
| 2019 Q1 | 1.68 Billion USD | 4.31% |
| 2019 Q3 | 1.76 Billion USD | 1.6% |
| 2019 Q2 | 1.73 Billion USD | 2.61% |
| 2019 FY | 1.75 Billion USD | 8.48% |
| 2018 Q4 | 1.62 Billion USD | 23.68% |
| 2018 Q2 | 1.29 Billion USD | 4.34% |
| 2018 Q3 | 1.3 Billion USD | 1.45% |
| 2018 Q1 | 1.23 Billion USD | 11.3% |
| 2018 FY | 1.62 Billion USD | 45.71% |
| 2017 Q2 | 1.05 Billion USD | 3.61% |
| 2017 Q4 | 1.11 Billion USD | 2.27% |
| 2017 FY | 1.11 Billion USD | 17.93% |
| 2017 Q1 | 1.01 Billion USD | 7.68% |
| 2017 Q3 | 1.08 Billion USD | 3.36% |
| 2016 Q2 | 814.96 Million USD | 1.44% |
| 2016 Q1 | 803.42 Million USD | 3.17% |
| 2016 Q3 | 928.75 Million USD | 13.96% |
| 2016 FY | 942.8 Million USD | 21.07% |
| 2016 Q4 | 942.8 Million USD | 1.51% |
| 2015 Q4 | 778.72 Million USD | 1.39% |
| 2015 Q1 | 740.02 Million USD | -0.96% |
| 2015 FY | 778.72 Million USD | 4.22% |
| 2015 Q3 | 768.03 Million USD | 1.71% |
| 2015 Q2 | 755.12 Million USD | 2.04% |
| 2014 FY | 747.16 Million USD | 2.59% |
| 2014 Q4 | 747.16 Million USD | 0.09% |
| 2014 Q3 | 746.5 Million USD | 0.32% |
| 2014 Q2 | 744.12 Million USD | 0.31% |
| 2014 Q1 | 741.81 Million USD | 1.86% |
| 2013 Q3 | 718.18 Million USD | -1.4% |
| 2013 Q4 | 728.28 Million USD | 1.41% |
| 2013 FY | 728.28 Million USD | 3.26% |
| 2013 Q1 | 712.13 Million USD | 0.97% |
| 2013 Q2 | 728.38 Million USD | 2.28% |
| 2012 Q4 | 705.3 Million USD | 35.85% |
| 2012 FY | 705.3 Million USD | 57.78% |
| 2012 Q2 | 500.15 Million USD | 2.2% |
| 2012 Q1 | 489.4 Million USD | 9.48% |
| 2012 Q3 | 519.18 Million USD | 3.8% |
| 2011 Q2 | 458.21 Million USD | 20.45% |
| 2011 Q4 | 447.01 Million USD | 6.73% |
| 2011 FY | 447.01 Million USD | 20.84% |
| 2011 Q1 | 380.41 Million USD | 2.96% |
| 2011 Q3 | 418.83 Million USD | -8.59% |
| 2010 Q3 | 364.04 Million USD | 29.92% |
| 2010 FY | 369.93 Million USD | 36.25% |
| 2010 Q2 | 280.21 Million USD | 1.11% |
| 2010 Q1 | 277.13 Million USD | 2.07% |
| 2010 Q4 | 369.48 Million USD | 1.49% |
| 2009 Q3 | 264.63 Million USD | 2.94% |
| 2009 Q4 | 271.51 Million USD | 2.6% |
| 2009 FY | 271.51 Million USD | 17.14% |
| 2009 Q2 | 257.06 Million USD | 6.6% |
| 2009 Q1 | 241.15 Million USD | 4.04% |
| 2008 Q4 | 231.77 Million USD | 1.69% |
| 2008 Q2 | 217.43 Million USD | 3.17% |
| 2008 Q3 | 227.92 Million USD | 4.82% |
| 2008 FY | 231.77 Million USD | 15.65% |
| 2008 Q1 | 210.75 Million USD | 5.16% |
| 2007 Q3 | 193.16 Million USD | 1.35% |
| 2007 Q4 | 200.42 Million USD | 3.76% |
| 2007 Q2 | 190.59 Million USD | 0.61% |
| 2007 Q1 | 189.44 Million USD | 3.71% |
| 2007 FY | 200.42 Million USD | 9.72% |
| 2006 Q3 | 177.1 Million USD | 2.54% |
| 2006 FY | 182.66 Million USD | 12.59% |
| 2006 Q1 | 166.07 Million USD | 2.36% |
| 2006 Q2 | 172.72 Million USD | 4.0% |
| 2006 Q4 | 182.66 Million USD | 3.14% |
| 2005 Q2 | 153.41 Million USD | 4.84% |
| 2005 FY | 162.24 Million USD | 15.99% |
| 2005 Q4 | 162.24 Million USD | 2.05% |
| 2005 Q3 | 158.98 Million USD | 3.63% |
| 2005 Q1 | 146.34 Million USD | 4.62% |
| 2004 Q2 | 125.49 Million USD | 8.31% |
| 2004 Q1 | 115.86 Million USD | 7.98% |
| 2004 FY | 139.87 Million USD | 30.36% |
| 2004 Q3 | 128.99 Million USD | 2.79% |
| 2004 Q4 | 139.87 Million USD | 8.44% |
| 2003 Q2 | 92.08 Million USD | 7.75% |
| 2003 Q4 | 107.3 Million USD | 7.46% |
| 2003 Q3 | 99.85 Million USD | 8.44% |
| 2003 FY | 107.3 Million USD | 37.03% |
| 2003 Q1 | 85.45 Million USD | 9.13% |
| 2002 FY | 78.3 Million USD | 17.47% |
| 2002 Q1 | 66.52 Million USD | -0.2% |
| 2002 Q4 | 78.3 Million USD | 5.0% |
| 2002 Q3 | 74.57 Million USD | 5.69% |
| 2002 Q2 | 70.55 Million USD | 6.06% |
| 2001 FY | 66.65 Million USD | -6.7% |
| 2001 Q1 | 70.21 Million USD | -1.73% |
| 2001 Q3 | 68.27 Million USD | -0.61% |
| 2001 Q2 | 68.69 Million USD | -2.17% |
| 2001 Q4 | 66.65 Million USD | -2.37% |
| 2000 Q2 | 76.24 Million USD | 1.61% |
| 2000 Q1 | 75.03 Million USD | 3.64% |
| 2000 FY | 71.44 Million USD | -1.32% |
| 2000 Q4 | 71.44 Million USD | -4.33% |
| 2000 Q3 | 74.68 Million USD | -2.04% |
| 1999 Q2 | 54 Million USD | 3.25% |
| 1999 Q3 | 68.6 Million USD | 27.04% |
| 1999 FY | 72.4 Million USD | 42.8% |
| 1999 Q4 | 72.4 Million USD | 5.54% |
| 1999 Q1 | 52.3 Million USD | 3.16% |
| 1998 Q1 | 45.6 Million USD | 0.66% |
| 1998 FY | 50.7 Million USD | 11.92% |
| 1998 Q2 | 45.9 Million USD | 0.66% |
| 1998 Q3 | 48.2 Million USD | 5.01% |
| 1998 Q4 | 50.7 Million USD | 5.19% |
| 1997 Q2 | 44.3 Million USD | 1.14% |
| 1997 Q1 | 43.8 Million USD | 5.04% |
| 1997 Q3 | 45.6 Million USD | 2.93% |
| 1997 Q4 | 45.3 Million USD | -0.66% |
| 1997 FY | 45.3 Million USD | 8.63% |
| 1996 Q4 | 41.7 Million USD | 9.74% |
| 1996 Q2 | 37.8 Million USD | 4.71% |
| 1996 Q1 | 36.1 Million USD | 4.64% |
| 1996 FY | 41.7 Million USD | 20.87% |
| 1996 Q3 | 38 Million USD | 0.53% |
| 1995 Q3 | 31.2 Million USD | 0.32% |
| 1995 Q4 | 34.5 Million USD | 10.58% |
| 1995 Q1 | 28.2 Million USD | 4.44% |
| 1995 Q2 | 31.1 Million USD | 10.28% |
| 1995 FY | 34.5 Million USD | 27.78% |
| 1994 Q1 | 23.8 Million USD | 16.1% |
| 1994 FY | 27 Million USD | 31.71% |
| 1994 Q4 | 27 Million USD | 5.06% |
| 1994 Q3 | 25.7 Million USD | 2.8% |
| 1994 Q2 | 25 Million USD | 5.04% |
| 1993 Q1 | 17.2 Million USD | 4.88% |
| 1993 Q3 | 18.9 Million USD | 9.25% |
| 1993 FY | 20.5 Million USD | 25.0% |
| 1993 Q4 | 20.5 Million USD | 8.47% |
| 1993 Q2 | 17.3 Million USD | 0.58% |
| 1992 FY | 16.4 Million USD | 74.47% |
| 1992 Q1 | 9.9 Million USD | 5.32% |
| 1992 Q2 | 15.3 Million USD | 54.55% |
| 1992 Q3 | 15.5 Million USD | 1.31% |
| 1992 Q4 | 16.4 Million USD | 5.81% |
| 1991 Q3 | 8.1 Million USD | 0.0% |
| 1991 FY | 9.4 Million USD | 154.05% |
| 1991 Q4 | 9.4 Million USD | 16.05% |
| 1990 FY | 3.7 Million USD | 131.25% |
| 1990 Q4 | 3.7 Million USD | 0.0% |
| 1989 Q4 | 1.6 Million USD | 0.0% |
| 1989 FY | 1.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | -1189.159% |
| AngioDynamics, Inc. | 317.67 Million USD | -631.966% |
| AtriCure, Inc. | 613.93 Million USD | -278.746% |
| Avinger, Inc. | 13.77 Million USD | -16786.304% |
| Azenta, Inc. | 2.88 Billion USD | 19.422% |
| BioLife Solutions, Inc. | 412.71 Million USD | -463.403% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 80.056% |
| Daxor Corporation | 34.86 Million USD | -6568.486% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -7940.819% |
| Femasys Inc. | 27.75 Million USD | -8277.499% |
| GlucoTrack, Inc. | 4.9 Million USD | -47305.586% |
| Harvard Bioscience, Inc. | 137.36 Million USD | -1592.736% |
| Hologic, Inc. | 9.15 Billion USD | 74.604% |
| ICU Medical, Inc. | 4.37 Billion USD | 46.893% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 84.942% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -8069.939% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | -570.528% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -37290.786% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -37290.786% |
| Masimo Corporation | 3.04 Billion USD | 23.549% |
| Microbot Medical Inc. | 8.32 Million USD | -27824.15% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -1252.552% |
| Nephros, Inc. | 11.86 Million USD | -19504.114% |
| NovoCure Limited | 1.14 Billion USD | -102.878% |
| NEXGEL, Inc. | 9.95 Million USD | -23257.549% |
| NEXGEL, Inc. | 9.95 Million USD | -23257.549% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | -775.907% |
| OraSure Technologies, Inc. | 482.84 Million USD | -381.572% |
| Pro-Dex, Inc. | 54.21 Million USD | -4189.327% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -3724.163% |
| Predictive Oncology Inc. | 14.41 Million USD | -16028.209% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -13648.611% |
| QuidelOrtho Corporation | 8.56 Billion USD | 72.846% |
| Repligen Corporation | 2.82 Billion USD | 17.673% |
| Sanara MedTech Inc. | 73.87 Million USD | -3047.702% |
| STAAR Surgical Company | 488.69 Million USD | -375.81% |
| Sharps Technology, Inc. | 11.78 Million USD | -19623.396% |
| Utah Medical Products, Inc. | 135.45 Million USD | -1616.579% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 68.45% |
| Jin Medical International Ltd. | 32.9 Million USD | -6966.87% |